A randomized, double-blind, experimental study evaluating the efficiency and safety for the VGuard device in the treatment of mild cognitive impairment (MCI).
Back to home
(+48) 666 069 834
(+48) 571 264 705
Biostat is responsible for eCRF development and data management.
Bioscience is responsible for project management and monitoring.
Wyślij nowe hasło